Dr. Kumar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
19 Tyler St
Ste 104
Nashua, NH 03060Phone+1 603-577-3065Fax+1 603-577-3066
Summary
- Dr. Amit Kumar is an allergist/immunologist in Nashua, NH and is affiliated with Southern New Hampshire Medical Center. He received his medical degree from State University of New York Upstate Medical University and has been in practice 10 years. He specializes in asthma & allergic conditions and is experienced in atopic dermatitis, asthma, food allergy, eczema, and allergies.
Education & Training
- Medical College of Wisconsin Affiliated HospitalsFellowship, Allergy and Immunology, 2007 - 2009
- Rutgers Health/Robert Wood Johnson Medical SchoolResidency, Internal Medicine, 2004 - 2007
- SUNY Upstate Medical UniversityClass of 2004
Certifications & Licensure
- NH State Medical License 2009 - 2025
- IN State Medical License 2015 - 2021
- MA State Medical License 2016 - 2019
- American Board of Allergy and Immunology Allergy & Immunology
- American Board of Internal Medicine Internal Medicine
- National Board of Physicians and Surgeons Allergy and Immunology
- National Board of Physicians and Surgeons Internal Medicine
Awards, Honors, & Recognition
- Top Doctor (Allergy Immunology) NH Magazine, 2014
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
- Top Doc Leading Vote Getter (Allergy Immunology) NH Magazine, 2011-2013
Publications & Presentations
PubMed
- 23 citationsEngagement of phytoestrogens in breast cancer suppression: Structural classification and mechanistic approachAnkur Kumar Tanwar, Neha Dhiman, Amit Kumar, Vikas Jaitak
European Journal of Medicinal Chemistry. 2021-03-05 - 22 citationsEpigenetic regulators of neuronal ferroptosis identify novel therapeutics for neurological diseases: HDACs, transglutaminases, and HIF prolyl hydroxylases.Orjon Rroji, Amit Kumar, Saravanan S. Karuppagounder, Rajiv R. Ratan
Neurobiology of Disease. 2021-01-01 - 4 citationsRecurrent SPECC1L-NTRK fusions in pediatric sarcoma and brain tumors.Dong-Anh Khuong-Quang, Lauren M Brown, Marie Wong, Chelsea Mayoh, Alexandra Sexton-Oates
Cold Spring Harbor Molecular Case Studies. 2020-12-01
Press Mentions
- As Anixa Starts Approaching the FDA, We Discuss Its Two Innovative ProgramsOctober 29th, 2018
- Why Tiny ITUS’s CAR-T Therapy Could Be a Big Deal in Cancer TreatmentSeptember 18th, 2018
- 9 AI-Based Initiatives Catalyzing Immunotherapy in 2018July 17th, 2018
- Join now to see all
Professional Memberships
- Fellow
- American College of Allergy, Asthma and ImmunologyFellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: